Evidence map›Paper›PMID 33721125›Full record

ReviewCurrent cardiology reports2021

Multimodality Imaging for Cardiac Evaluation in Patients with COVID-19.

Erin Goerlich, Anum S Minhas, Monica Mukherjee, Farooq H Sheikh, Nisha A Gilotra, Garima Sharma, Erin D Michos, Allison G Hays

Abstract readReview
In one paragraph

Review in Current cardiology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Cardiovascular effects of the post-COVID-19 condition.Nature cardiovascular research · 2024
    Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. COVID and Cardiovascular Disease: What We Know in 2021.Current atherosclerosis reports · 2021
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Erin GoerlichDivision of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Carnegie 568, Baltimore, MD, 21287, USA.ORCID https://orcid.org/0000-0002-7708-8413
Anum S MinhasDivision of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Carnegie 568, Baltimore, MD, 21287, USA.ORCID https://orcid.org/0000-0001-6680-0404
Monica MukherjeeDivision of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Carnegie 568, Baltimore, MD, 21287, USA.ORCID https://orcid.org/0000-0001-6088-0773
Farooq H SheikhDivision of Cardiology, Department of Medicine, Medstar Washington Hospital Center, Washington, DC, USA.ORCID https://orcid.org/0000-0001-9687-9475
Nisha A GilotraDivision of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Carnegie 568, Baltimore, MD, 21287, USA.ORCID https://orcid.org/0000-0002-4511-8008
Garima SharmaDivision of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Carnegie 568, Baltimore, MD, 21287, USA.ORCID https://orcid.org/0000-0001-7254-2077
Erin D MichosDivision of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Carnegie 568, Baltimore, MD, 21287, USA.ORCID https://orcid.org/0000-0002-5547-5084
Allison G HaysDivision of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Carnegie 568, Baltimore, MD, 21287, USA. ahays2@jhmi.edu.ORCID http://orcid.org/0000-0003-2138-1589

Funding

PATHOPHYSIOLOGY OF MYOCARDIAL DISEASEST32HL007227 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Chulan Kwon, WENDY S POST · 1985 to 2026
$21.2M
CARDIOVASCULAR EPIDEMIOLOGY INSTITUTIONAL TRAININGT32HL007024 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Elizabeth Selvin · 1985 to 2026
$17.5M
NHLBI NIH HHS T32 HL007024NIH HHS 1R01HL147660NIH HHS T32HL007024NIH HHS T32HL007227
6 · The paper itself

Abstract

purpose of reviewA growing number of cardiovascular manifestations resulting from the novel SARS-CoV-2 coronavirus (COVID-19) have been described since the beginning of this global pandemic. Acute myocardial injury is common in this population and is associated with higher rates of morbidity and mortality. The focus of this review centers on the recent applications of multimodality imaging in the diagnosis and management of COVID-19-related cardiovascular conditions. RECENT

findingsIn addition to standard cardiac imaging techniques such as transthoracic echocardiography, other modalities including computed tomography and cardiac magnetic resonance imaging have emerged as useful adjuncts in select patients with COVID-19 infection, particularly those with suspected ischemic and nonischemic myocardial injury. Data have also emerged suggesting lasting COVID-19 subclinical cardiac effects, which may have long-term prognostic implications. With the spectrum of COVID-19 cardiovascular manifestations observed thus far, it is important for clinicians to recognize the role, strengths, and limitations of multimodality imaging techniques in this patient population.

Indexed as

COVID-19HeartHumansMultimodal ImagingPandemicsSARS-CoV-2CardiovascularCOVID-19Multimodality imagingMyocardial injury

Identifiers

PMID33721125
PMCPMC7957471

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.